AVITA Medical Submits FDA PMA Supplement for RECELL GO
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of…
Browsing Tag
Australian Stock Exchange:AVH.AX
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo…
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces Update to Automation Device
<!-- Name:DistributionId Value:8807797 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
<!-- Name:DistributionId Value:8790117 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
VALENCIA, Calif., and MELBOURNE, Australia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical® to Host Investor Webinar Briefing
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of…
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
Investor Webinar Briefing
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
RECELL® System Data to be Presented at the Controversies and Conversations in Laser…
VALENCIA, Calif. and MELBOURNE, Australia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and…